Douglas Dorsey
Pulmonary Disease · Salem, VANPI 1861437592
Payments from drug & device makers
$17,664in general payments, 2019–2025
Across 994 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Actelion Pharmaceuticals US, Inc.$1K
- Boehringer Ingelheim$1K
- Genentech USA, Inc.$1K
- Sanofi$1K
- plus $8K from 33 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 193 | $2,191 |
| AstraZeneca | 104 | $2,107 |
| Actelion Pharmaceuticals US, Inc. | 56 | $1,395 |
| Boehringer Ingelheim | 71 | $1,369 |
| Genentech USA, Inc. | 58 | $1,266 |
| Sanofi | 50 | $1,117 |
| Mylan Specialty L.p. | 58 | $1,065 |
| Mallinckrodt Hospital Products Inc. | 60 | $958 |
| United Therapeutics Corporation | 40 | $859 |
| Regeneron Healthcare Solutions, Inc. | 24 | $580 |
| Sunovion Pharmaceuticals Inc. | 37 | $551 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $542 |
| Novartis | 25 | $444 |
| Teva Pharmaceuticals USA, Inc. | 26 | $378 |
| La Jolla Pharmaceutical Company | 17 | $248 |
| Grifols USA, LLC | 11 | $245 |
| Merck | 15 | $228 |
| ANI Pharmaceuticals, Inc. | 8 | $203 |
| Johnson & Johnson(2 entities) | 14 | $202 |
| Insmed, Inc. | 12 | $196 |
| Amgen | 10 | $167 |
| Sanofi-aventis U.S. LLC | 2 | $162 |
| Mallinckrodt Enterprises LLC | 13 | $159 |
| Inogen, Inc. | 8 | $144 |
| Gilead | 8 | $131 |
| Pulmonx Corporation | 3 | $125 |
| E.r. Squibb & Sons, L.L.C. | 9 | $121 |
| Electromed, Inc. | 9 | $113 |
| Baxter Healthcare | 5 | $92 |
| Bayer | 5 | $84 |
| Shire North American Group Inc | 3 | $44 |
| Philips North America LLC | 3 | $40 |
| Pharming Healthcare, Inc. | 2 | $37 |
| CSL Behring | 1 | $24 |
| Inari Medical, Inc. | 1 | $21 |
| Acacia Pharma Inc | 1 | $17 |
| Itamar Medical Inc | 1 | $14 |
| Pfizer | 1 | $14 |
| Vapotherm Inc | 1 | $11 |
How this compares
$17,664 in reported general payments places this provider in the 80th percentile of 317 pulmonary disease providers in Virginia.
Other pulmonary disease in Salem
- James WittenSalem$119K
- David KilleenSalem$47K
- Nelson GreeneSalem$31K
- Steven NathanFalls Church$2.5M
- Shilpa JohriRichmond$1.7M
- Omar MinaiHopewell$1.3M
- Vijay SubramaniamWilliamsburg$1.3M
- Rabih HalabiFalls Church$604K
- Patricia SimeRichmond$572K
- Apostolos PerelasRichmond$567K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.